Drugs for Vulvovaginal Candidiasis Market Impact of AI and Automation The global market for drugs targeting vulvovaginal candidiasis was valued at approximately $1.2 billion in 2022, with a compound annual growth rate (CAGR) of 4.5% projected through 2030. This market includes both over-the-counter and prescription medications, addressing a common fungal infection affecting women worldwide. The… Continue reading Global Drugs for Vulvovaginal Candidiasis Market Impact of AI and Automation